• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠T细胞的转化需要MYC和AKT活性以及对内在凋亡的抑制。

Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis.

作者信息

Högstrand Kari, Darmanin Stephanie, Forshell TachaZi Plym, Grandien Alf

机构信息

Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Huddinge, 141 57 Stockholm, Sweden.

出版信息

Oncotarget. 2018 Apr 20;9(30):21396-21410. doi: 10.18632/oncotarget.25113.

DOI:10.18632/oncotarget.25113
PMID:29765548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5940390/
Abstract

Peripheral T-cell lymphoma is an aggressive non-Hodgkin's lymphoma characterized by excessive proliferation of transformed mature T cells. The number and nature of genetic aberrations required and sufficient for transformation of normal T cells into lymphomas is unknown. Here, using a combinatorial -approach, we demonstrate that overexpression of MYC together with activated AKT in conditions of inhibition of intrinsic apoptosis rapidly resulted in transformation of mature mouse T cells with a frequency approaching 100%. Injection of transformed cells into mice resulted in rapid development of aggressive T cell lymphoma, characterized by spread to several organs, destruction of tissue architecture and rapid death of the animals. TcR-sequencing revealed a polyclonal repertoire of tumor cells indicating that co-expression of MYC, activated AKT and BCLXL is sufficient for tumor transformation and do not require acquisition of additional genetic events. When analyzing cells with inducible expression we found that proliferation of transformed T cells required sustained expression of both MYC and AKT. AKT exerted a dual function as it inhibited induction of, and promoted exit from, cellular quiescence and contributed to inhibion of apoptosis. Downregulation of AKT and/or MYC together with BCLXL resulted in rapid and complete elimination of cells through induction of apoptotic cell death.

摘要

外周T细胞淋巴瘤是一种侵袭性非霍奇金淋巴瘤,其特征为转化成熟T细胞过度增殖。正常T细胞转化为淋巴瘤所需且足够的基因畸变的数量和性质尚不清楚。在此,我们采用组合方法证明,在抑制内源性凋亡的条件下,MYC的过表达与激活的AKT共同作用,能迅速导致成熟小鼠T细胞转化,频率接近100%。将转化细胞注射到小鼠体内会导致侵袭性T细胞淋巴瘤迅速发展,其特征为扩散至多个器官、组织结构破坏以及动物快速死亡。TcR测序显示肿瘤细胞具有多克隆谱系,表明MYC、激活的AKT和BCLXL的共表达足以实现肿瘤转化,且不需要获得额外的基因事件。在分析可诱导表达的细胞时,我们发现转化T细胞的增殖需要MYC和AKT的持续表达。AKT发挥双重功能,它抑制细胞静止的诱导并促进细胞从静止状态退出,同时有助于抑制凋亡。AKT和/或MYC与BCLXL一起下调会通过诱导凋亡性细胞死亡导致细胞迅速且完全清除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/2e4af1de8b84/oncotarget-09-21396-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/df23139a8d92/oncotarget-09-21396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/4591010ee476/oncotarget-09-21396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/4102392b6535/oncotarget-09-21396-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/da4a60b8dc2a/oncotarget-09-21396-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/a9ad6f152a4a/oncotarget-09-21396-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/2e4af1de8b84/oncotarget-09-21396-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/df23139a8d92/oncotarget-09-21396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/4591010ee476/oncotarget-09-21396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/4102392b6535/oncotarget-09-21396-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/da4a60b8dc2a/oncotarget-09-21396-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/a9ad6f152a4a/oncotarget-09-21396-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/5940390/2e4af1de8b84/oncotarget-09-21396-g006.jpg

相似文献

1
Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis.小鼠T细胞的转化需要MYC和AKT活性以及对内在凋亡的抑制。
Oncotarget. 2018 Apr 20;9(30):21396-21410. doi: 10.18632/oncotarget.25113.
2
MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.MYC 驱动的成熟鼠 B 细胞恶性转化需要同时抑制内在凋亡和 p53 活性。
Eur J Immunol. 2019 Mar;49(3):375-385. doi: 10.1002/eji.201847585. Epub 2018 Oct 12.
3
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.同时靶向Akt和Myc可抑制来自Lck-Dlx5小鼠的淋巴瘤细胞的活力。
Cancer Biol Ther. 2015;16(4):580-8. doi: 10.1080/15384047.2015.1018495. Epub 2015 Mar 20.
4
NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.NF-κB/STAT3/PI3K 信号转导在 iMyc E μ B 淋巴瘤中的相互作用。
Mol Cancer. 2010 Apr 30;9:97. doi: 10.1186/1476-4598-9-97.
5
Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.Myc激活在由AKT和RAS途径激活诱导的小鼠肝癌发生中的关键作用。
Oncogene. 2017 Sep 7;36(36):5087-5097. doi: 10.1038/onc.2017.114. Epub 2017 May 8.
6
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.AKT 信号通路对于核糖体 RNA 的合成以及体内 Eμ-Myc B 细胞淋巴瘤的进展是必需的。
FEBS J. 2013 Nov;280(21):5307-16. doi: 10.1111/febs.12135. Epub 2013 Feb 13.
7
c-MYC overexpression overrides TAK1 dependency in efficient tumorigenicity of AKT-transformed cells.c-MYC 过表达可克服 AKT 转化细胞高效致瘤性中的 TAK1 依赖性。
Cancer Lett. 2013 Aug 19;336(2):290-8. doi: 10.1016/j.canlet.2013.03.014. Epub 2013 Mar 21.
8
Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.Bcl-2与c-Myc在爱泼斯坦-巴尔病毒永生化的人B细胞系GM607中协同作用,但不赋予致瘤性。
Leuk Lymphoma. 2005 Apr;46(4):581-92. doi: 10.1080/10428190400019867.
9
Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.抑制内在而非外在凋亡途径会加速并促使 MYC 驱动的肿瘤发生向急性髓系白血病转化。
PLoS One. 2012;7(2):e31366. doi: 10.1371/journal.pone.0031366. Epub 2012 Feb 29.
10
The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.E-Id蛋白轴调节PI3K-AKT-mTORC1-Hif1a和c-myc/p19Arf信号通路的活性,以抑制先天性变异TFH细胞发育、胸腺细胞扩增和淋巴瘤发生。
Genes Dev. 2015 Feb 15;29(4):409-25. doi: 10.1101/gad.255331.114.

引用本文的文献

1
Differential Transcriptional Reprogramming by Wild Type and Lymphoma-Associated Mutant MYC Proteins as B-Cells Convert to a Lymphoma Phenotype.野生型和淋巴瘤相关突变型MYC蛋白在B细胞转变为淋巴瘤表型过程中的差异转录重编程
Cancers (Basel). 2021 Dec 3;13(23):6093. doi: 10.3390/cancers13236093.
2
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.DNMT1 对 NPM-ALK 驱动的淋巴瘤发生进行表观基因组重编程的需求。
Life Sci Alliance. 2020 Dec 11;4(2). doi: 10.26508/lsa.202000794. Print 2021 Feb.

本文引用的文献

1
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.在血管免疫母细胞性和其他滤泡辅助 T 细胞来源的淋巴瘤中,与 TCR 信号相关的基因中的激活突变。
Blood. 2016 Sep 15;128(11):1490-502. doi: 10.1182/blood-2016-02-698977. Epub 2016 Jul 1.
2
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
3
The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
多梳抑制复合体通路在T细胞和自然杀伤细胞淋巴瘤中的作用:生物学及预后意义
Tumour Biol. 2016 Feb;37(2):2037-47. doi: 10.1007/s13277-015-3977-y. Epub 2015 Sep 4.
4
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.趋同突变和激酶融合导致间变性大细胞淋巴瘤中致癌性STAT3激活。
Cancer Cell. 2015 Apr 13;27(4):516-32. doi: 10.1016/j.ccell.2015.03.006.
5
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.在淋巴系统恶性肿瘤中,通过阻止PI3K/AKT/mTOR激活,可以克服对BCL-2抑制剂ABT-199的MCL-1和BCL-xL依赖性耐药。
Cell Death Dis. 2015 Jan 15;6(1):e1593. doi: 10.1038/cddis.2014.525.
6
Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.外周 T 细胞和 NK 细胞淋巴增殖性疾病:起源细胞、临床及病理意义
Immunol Rev. 2015 Jan;263(1):124-59. doi: 10.1111/imr.12248.
7
Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.TET2功能降低会导致小鼠出现具有滤泡辅助性T细胞样特征的T细胞淋巴瘤。
Blood Cancer J. 2014 Dec 12;4(12):e264. doi: 10.1038/bcj.2014.83.
8
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.Dnmt3a 缺失使小鼠造血干细胞易于恶性转化。
Blood. 2015 Jan 22;125(4):629-38. doi: 10.1182/blood-2014-08-594648.
9
MYC and the control of apoptosis.MYC与细胞凋亡的调控
Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a014407. doi: 10.1101/cshperspect.a014407.
10
Rho-GTPases as key regulators of T lymphocyte biology.Rho-GTP酶作为T淋巴细胞生物学的关键调节因子。
Small GTPases. 2014;5. doi: 10.4161/sgtp.28208. Epub 2014 May 8.